ADGRL4 and colorectal neoplasm: More importantly, the growth of human ovarian and colorectal tumour xenografts were substantially inhibited using anti-mouse Eltd1 silencing [8], suggesting ELTD1 is a potential target for anti-angiogeneic therapy.